Quantcast
Last updated on April 18, 2014 at 8:42 EDT

Latest Genetic disorders Stories

2012-06-14 10:23:12

Lines in US registry will help studies on Huntington's disease, hemophilia & more ANN ARBOR, Mich., June 14, 2012 /PRNewswire-USNewswire/ -- Six new human embryonic stem cell lines derived at the University of Michigan have just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. U-M now has a total of eight cell lines on the registry, including five that carry genetic mutations for serious diseases such as the...

2012-06-13 10:23:58

Letter Signed by Nearly 120 Organizations, Latest PDUFA-Oriented Action HACKENSACK, N.J., June 13, 2012 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD), the nation's largest Duchenne muscular dystrophy (Duchenne) advocacy organization - co-led a letter to key lawmakers that was signed by 119 organizations and that urges Congress to include the strongest patient engagement and rare disease provisions within the final use fee legislation. (Logo:...

2012-06-13 02:26:59

ROCKVILLE, Md., June 13, 2012 /PRNewswire/ -- This week's announcement by ABC News' Robin Roberts that she has been diagnosed with MDS (myelodysplastic syndrome) has drawn national attention to this bone marrow failure disorder. Since 1983, the Aplastic Anemia & MDS International Foundation (www.AAMDS.org) has provided education and support to patients with MDS. MDS is a group of rare disorders affecting the bone marrow. People with MDS have an abnormal number of red and white blood...

2012-06-11 23:03:39

Models will facilitate a better understanding of the disease and aid in therapeutic development. Sioux Center, Iowa (PRWEB) June 11, 2012 CHDI Foundation, Inc. and Exemplar Genetics today announced a collaborative research agreement to create multiple miniature swine models of Huntington´s disease (HD), a devastating disorder for which there are currently no effective treatments. Models that mimic this debilitating disease are anticipated to accelerate both the understanding of the...

2012-06-11 23:00:42

HUNTINGTON´S DISEASE, for the FIRST time in history was treated in March 2012 by Dr.´s Feinerman and Paino in our state of the art clinic in Lima, Peru. Two sisters with this debilitating disease will be followed over the next year after a very successful treatment. You can follow the progress and see other testimonials on our website, http://www.stemcellregenmed.com Aventura, North Miami, Florida (PRWEB) June 11, 2012 In a time of such an amazing biotechnology medical era in...

2012-06-08 02:23:54

KING OF PRUSSIA, Pa., June 8, 2012 /PRNewswire/ -- CSL Behring announced today that the company has been granted Orphan Drug Designation by the United States Food and Drug Administration for its novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP). The Orphan Drug Designation is granted for the treatment and prophylaxis of bleeding episodes in patients with congenital factor IX deficiency (hemophilia B). The designation includes routine prophylaxis...

Fetal Genome Mapped Through Maternal-Paternal DNA
2012-06-07 10:34:23

Scientists have successfully sequenced the genome of a fetus after taking a blood sample from a woman who was 18 weeks pregnant, and a swab of saliva from the father -- a move that could play a significant role in the screening of rare disorders before the child is even born. The research, published in the journal Science Translational Medicine, is not the first study to have shown a fetal genome can be glimpsed with a sample of the mother´s blood, but does offer a more accurate...

2012-06-06 23:01:31

RDS Runners share their stories on why they are running for Down syndrome research. Chicago, IL (PRWEB) June 06, 2012 Research Down Syndrome and its national RDS Runners Charity Racing Program observes June 6, National Running Day by spotlighting three RDS Runners participating in races as fundraisers for Down syndrome research. Our featured runners have a daugther, a brother and a future nephew with Down syndrome. They share in a commitment to have their miles support the RDS mission to...

2012-06-06 12:22:39

Seizure severity and antiepileptic drug polytherapy among predictors of poor seizure outcomes A 25-year follow-up study reveals that 68% of patients with juvenile myoclonic epilepsy (JME) became seizure-free, with nearly 30% no longer needing antiepileptic drug (AED) treatment. Findings published today in Epilepsia, a journal of the International League Against Epilepsy (ILAE), report that the occurrence of generalized tonic-clonic seizures preceded by bilateral myoclonic seizures, and AED...

2012-06-05 23:03:15

Revolutionary dietary supplement from Neogenis® Labs supported struggling teen´s circulation and helped his body normalize blood pressure. Austin, TX (PRWEB) June 05, 2012 In the spring of 2010, Baylor College of Medicine's (BCM) Dr. Brendan Lee received a desperate email from the mother of one of his patients. The teen — who had been Lee's patient for most of his life — was in hypertensive crisis and none of the usual treatments could bring his blood pressure down to...


Latest Genetic disorders Reference Libraries

44_b4e6022f2dde476f8bd4cab961972a2d
2007-12-13 19:44:51

The Munchkin is a fairly new breed of cat with a lot of controversy surrounding it. The breed is created by a mutation that causes achondroplasia, or hypochondroplasia, which results in the cats having abnormally short legs. The breed originated when a pregnant, short-legged black cat was discovered in Louisiana in 1983. One of her kittens, a tomcat, became the father of the breeding program for Munchkins. Several cat registries refuse to recognize the breed due to the controversy that...

More Articles (1 articles) »